These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 23422395

  • 1. Switching from clozapine to zotepine in patients with schizophrenia: a 12-week prospective, randomized, rater blind, and parallel study.
    Lin CC, Chiu HJ, Chen JY, Liou YJ, Wang YC, Chen TT, Bai YM.
    J Clin Psychopharmacol; 2013 Apr; 33(2):211-4. PubMed ID: 23422395
    [Abstract] [Full Text] [Related]

  • 2. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ, Riedel M, Müller N, Fischer W, Kohnen R.
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [Abstract] [Full Text] [Related]

  • 3. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
    Nielsen J, Emborg C, Gydesen S, Dybbro J, Aagaard J, Haderup K, Glyngdal P, Fabricius S, Thode D, Lublin H, Andersen T, Damkier P, Taylor D.
    J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
    [Abstract] [Full Text] [Related]

  • 4. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY, Lin AS, Chen KP, Cheng JS, Chen YY, Tsai CJ.
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [Abstract] [Full Text] [Related]

  • 5. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M, Raniwalla J, Tweed J, Leutenegger E, Dollfus S, Kelly F.
    Psychopharmacol Bull; 1996 Dec; 32(1):81-7. PubMed ID: 8927680
    [Abstract] [Full Text] [Related]

  • 6. Zotepine versus other atypical antipsychotics for schizophrenia.
    Subramanian S, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Kissling W, Leucht S, Komossa K.
    Cochrane Database Syst Rev; 2010 Oct 06; (10):CD006628. PubMed ID: 20927748
    [Abstract] [Full Text] [Related]

  • 7. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients].
    Klieser E, Lehmann E, Tegeler J.
    Fortschr Neurol Psychiatr; 1991 Sep 06; 59 Suppl 1():14-7. PubMed ID: 1683333
    [Abstract] [Full Text] [Related]

  • 8. Zotepine versus other atypical antipsychotics for schizophrenia.
    Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Kissling W, Leucht S.
    Cochrane Database Syst Rev; 2010 Jan 20; (1):CD006628. PubMed ID: 20091601
    [Abstract] [Full Text] [Related]

  • 9. [Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness].
    Wetzel H, von Bardeleben U, Holsboer F, Benkert O.
    Fortschr Neurol Psychiatr; 1991 Sep 20; 59 Suppl 1():23-9. PubMed ID: 1683336
    [Abstract] [Full Text] [Related]

  • 10. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C, Accordini S, Nosè M, Stroup S, Purgato M, Girlanda F, Esposito E, Veronese A, Tansella M, Cipriani A, CHAT (Clozapine Haloperidol Aripiprazole Trial) Study Group.
    J Clin Psychopharmacol; 2011 Jun 20; 31(3):266-73. PubMed ID: 21508849
    [Abstract] [Full Text] [Related]

  • 11. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia.
    Cooper SJ, Tweed J, Raniwalla J, Butler A, Welch C.
    Acta Psychiatr Scand; 2000 Mar 20; 101(3):218-25. PubMed ID: 10721870
    [Abstract] [Full Text] [Related]

  • 12. A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania.
    Chan HY, Jou SH, Juang YY, Chang CJ, Chen JJ, Chen CH, Chiu NY.
    Psychiatry Clin Neurosci; 2010 Apr 20; 64(2):162-9. PubMed ID: 20447012
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR, Pandolfo G, Micò U, Lamberti Castronuovo E, Abenavoli E, Scimeca G, Spina E, Zoccali R, Bruno A.
    J Clin Psychopharmacol; 2014 Feb 20; 34(1):129-33. PubMed ID: 24145221
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol.
    Hwang TJ, Lin SK, Lin HN.
    J Formos Med Assoc; 2001 Dec 20; 100(12):811-6. PubMed ID: 11802520
    [Abstract] [Full Text] [Related]

  • 15. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM, Ackenheil M, Müller-Spahn F, Kapfhammer HP.
    Pharmacopsychiatry; 1987 Feb 20; 20(1 Spec No):52-7. PubMed ID: 2883683
    [Abstract] [Full Text] [Related]

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 20; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 17. Low-dose zotepine in the maintenance treatment of schizophrenia.
    Fleischhacker WW, Stuppäck C, Barnas C, Unterweger B, Hinterhuber H.
    Pharmacopsychiatry; 1987 Feb 20; 20(1 Spec No):61-3. PubMed ID: 2883685
    [Abstract] [Full Text] [Related]

  • 18. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D, Fernandes BS, Berk M, Dodd S, Medeiros DW, Pedrini M, Kunz M, Gomes FA, Giglio LF, Lobato MI, Belmonte-de-Abreu PS, Gama CS.
    J Clin Psychiatry; 2009 Oct 20; 70(10):1416-23. PubMed ID: 19906345
    [Abstract] [Full Text] [Related]

  • 19. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C, Stuppäck CH, Miller C, Haring C, Sperner-Unterweger B, Fleischhacker WW.
    Fortschr Neurol Psychiatr; 1991 Sep 20; 59 Suppl 1():36-40. PubMed ID: 1683338
    [Abstract] [Full Text] [Related]

  • 20. Zotepine in the prevention of recurrence: a randomised, double-blind, placebo-controlled study for chronic schizophrenia.
    Cooper SJ, Butler A, Tweed J, Welch C, Raniwalla J.
    Psychopharmacology (Berl); 2000 Jun 20; 150(3):237-43. PubMed ID: 10923750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.